nejm semaglutide ckd The Effects of on Health-Related Quality of Life in Adults with Type 2 Diabetes and CKD: FLOW trial The FLOW trial: #semaglutide significantly

Contrary to pancreatic -cells, the mechanism of GLP-1 stimulation-secretion coupling in intestinal L-cells is poorly understood 32

Weight loss is a big deal whether you want to become healthier or just look better

This is important because a huge number of people have insulin resistance (up to 2/3rds of people in the United States), and insulin resistance is a known contributor to obesity

Biochem Pharmacol 229:116471 Kelly CA, Sipos JA (2024) Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists

Interestingly, a separate drug currently in late-stage development, MariTide (maridebart cafraglutide), is built on the opposite premise: blocking the GIP receptor rather than activating it

1 Safety The most common adverse effect of semaglutide is an increase in heart rate, with an increase of 10 to 19 beats per minute in 41% of patients (34% with placebo) and 20 beats per minute in 26% of patients (vs